Following a phase 2 study, Moderna submitted initial data to the FDA for the approval of its COVID-19 booster shot that would be administered 6 months after an individual’s second dose. Moderna submitted initial data to the FDA based on the results of a phase 2 trial that demonstrated the efficacy of a booster shot […]